Resultados de procura - Michael Bonelli

Limitar resultados
  1. 1
    Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases

    Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases por Daniella M. Schwartz, Michael Bonelli, Massimo Gadina, John J. O’Shea

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Phenotypic and Functional Analysis of CD4+CD25−Foxp3+ T Cells in Patients with Systemic Lupus Erythematosus

    Phenotypic and Functional Analysis of CD4+CD25−Foxp3+ T Cells in Patients with Systemic Lupus Erythematosus por Michael Bonelli, A Savitskaya, Carl-Walter Steiner, Eva Rath, Josef S Smolen, Clemens Scheinecker

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Strain-Specific Properties and T Cells Regulate the Susceptibility to Papilloma Induction by Mus musculus Papillomavirus 1

    Strain-Specific Properties and T Cells Regulate the Susceptibility to Papilloma Induction by Mus musculus Papillomavirus 1 por Alessandra Handisurya, Patricia M. Day, Cynthia D. Thompson, Michael Bonelli, Douglas R. Lowy, John T. Schiller

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)

    Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE) por Michael Bonelli, Anastasya Savitskaya, K Dalwigk, C. W. Steiner, Daniel Aletaha, Josef S Smolen, Clemens Scheinecker

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    CD4+CD25-Foxp3+ T cells: a marker for lupus nephritis?

    CD4+CD25-Foxp3+ T cells: a marker for lupus nephritis? por Michael Bonelli, Lisa Göschl, Stephan Blüml, Thomas Karonitsch, Carl-Walter Steiner, G Steiner, Josef S Smolen, Clemens Scheinecker

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis

    Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis por Michael Bonelli, Lisa Göschl, Stephan Blüml, Thomas Karonitsch, Kiyoshi Hirahara, Elisabeth Ferner, Carl-Walter Steiner, G Steiner, Josef S Smolen, Clemens Scheinecker

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs

    Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs por Massimo Gadina, Catrina Johnson, Daniella M. Schwartz, Michael Bonelli, Sarfaraz Hasni, Yuka Kanno, Paul S. Changelian, Arian Laurence, John J. O’Shea

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story

    Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story por Michael Bonelli, Andreas Kerschbaumer, Kastriot Kastrati, Kamran Ghoreschi, Massimo Gadina, Leonhard X. Heinz, Josef S Smolen, Daniel Aletaha, John J. O’Shea, Arian Laurence

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Helper T Cell Plasticity: Impact of Extrinsic and Intrinsic Signals on Transcriptomes and Epigenomes

    Helper T Cell Plasticity: Impact of Extrinsic and Intrinsic Signals on Transcriptomes and Epigenomes por Michael Bonelli, Han‐Yu Shih, Kiyoshi Hirahara, Kentner Singelton, Arian Laurence, Amanda C. Poholek, Tim Hand, Yohei Mikami, Golnaz Vahedi, Yuka Kanno, John J. O’Shea

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Transcriptional and epigenetic networks of helper T and innate lymphoid cells

    Transcriptional and epigenetic networks of helper T and innate lymphoid cells por Han‐Yu Shih, Giuseppe Sciumè, Amanda C. Poholek, Golnaz Vahedi, Kiyoshi Hirahara, Alejandro V. Villarino, Michael Bonelli, Rémy Bosselut, Yuka Kanno, Stefan A. Muljo, John J. O’Shea

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    Abatacept (CTLA‐4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis

    Abatacept (CTLA‐4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis por Michael Bonelli, Elisabeth Ferner, Lisa Göschl, Stephan Blüml, Anastasiya Hladik, Thomas Karonitsch, H. Kiener, Ruth A. Byrne, Birgit Niederreiter, C. W. Steiner, Eva Rath, Michael Bergmann, Josef S Smolen, Clemens Scheinecker

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion

    EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion por Xiang‐Ping Yang, Kan Jiang, Kiyoshi Hirahara, Golnaz Vahedi, Behdad Afzali, Giuseppe Sciumè, Michael Bonelli, Hong‐Wei Sun, Dragana Janković, Yuka Kanno, Vittorio Sartorelli, John J. O’Shea, Arian Laurence

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions

    Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions por Alejandro V. Villarino, Arian Laurence, Gertraud W. Robinson, Michael Bonelli, Bárbara Dema, Behdad Afzali, Han‐Yu Shih, Hong‐Wei Sun, Stephen R. Brooks, Lothar Hennighausen, Yuka Kanno, John J. O’Shea

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes

    IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes por Michael Bonelli, K Dalwigk, Alexander Platzer, Isabel Olmos Calvo, Silvia Hayer, Birgit Niederreiter, Johannes Holinka, Florian Sevelda, Thomas Pap, G Steiner, Giulio Superti‐Furga, Josef S Smolen, Hans P. Kiener, Thomas Karonitsch

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Autoreactive IgE Is Prevalent in Systemic Lupus Erythematosus and Is Associated with Increased Disease Activity and Nephritis

    Autoreactive IgE Is Prevalent in Systemic Lupus Erythematosus and Is Associated with Increased Disease Activity and Nephritis por Bárbara Dema, Christophe Pellefigues, Sarfaraz Hasni, Nathalie Gault, Chao Jiang, Tiffany K. Ricks, Michael Bonelli, Jörg Scheffel, Karim Sacré, Mathieu Jablonski, Delphine Gobert, T. Papo, Éric Daugas, Gabor G. Illei, Nicolas Charles, Juan Rivera

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Preclinical models of arthritis for studying immunotherapy and immune tolerance

    Preclinical models of arthritis for studying immunotherapy and immune tolerance por Gavin R. Meehan, Ranjeny Thomas, Shaima Al‐Khabouri, Pascale Wehr, Catharien M. U. Hilkens, David C. Wraith, Daniela Sieghart, Michael Bonelli, György Nagy, Paul Garside, David F. Tough, Huw D. Lewis, James M. Brewer

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  17. 17
    Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workers

    Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workers por Helga Radner, Daniela Sieghart, Anselm Jorda, Clemens Fedrizzi, Timothy Hasenöhrl, Andrej Zdravkovic, Monika Redlberger‐Fritz, Elisabeth Puchammer-Stoeckl, Karolina Anderle, Felix Bergmann, Christa Firbas, Galateja Jordakieva, Barbara Wagner, Helmuth Haslacher, Thomas Perkmann, Leonhard X. Heinz, Michael Bonelli, Richard Crevenna, Daniel Aletaha, Markus Zeitlinger

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity

    Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity por Kiyoshi Hirahara, Atsushi Onodera, Alejandro V. Villarino, Michael Bonelli, Giuseppe Sciumè, Arian Laurence, Hong‐Wei Sun, Stephen R. Brooks, Golnaz Vahedi, Han‐Yu Shih, Gustavo Gutierrez-Cruz, S. Iwata, Ryo Suzuki, Yohei Mikami, Yoshitaka Okamoto, Toshinori Nakayama, Steven M. Holland, Christopher A. Hunter, Yuka Kanno, John J. O’Shea

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    MicroRNA-146a governs fibroblast activation and joint pathology in arthritis

    MicroRNA-146a governs fibroblast activation and joint pathology in arthritis por Victoria Saferding, Antonia Puchner, Eliana Gonçalves‐Alves, Melanie Hofmann, Michael Bonelli, Julia Brunner, Emine Sahin, Birgit Niederreiter, Silvia Hayer, Hans P. Kiener, Elisa Einwallner, Ramzi Nehmar, Raphaël Carapito, Philippe Georgel, Marije I. Koenders, Mark Boldin, Gernot Schabbauer, Mariola Kurowska‐Stolarska, G Steiner, Josef S Smolen, Kurt Redlich, Stephan Blüml

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study

    Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study por Daniel Mrak, Elisabeth Simader, Daniela Sieghart, Péter Mandl, Helga Radner, Thomas Perkmann, Helmuth Haslacher, Margareta Mayer, Maximilian Koblischke, Philipp Hofer, Lisa Göschl, Felix Kartnig, Thomas Deimel, Andreas Kerschbaumer, Thomas Hummel, Barbara Kornek, Renate Thalhammer, Karin Stiasny, Stefan Winkler, Josef S Smolen, Judith H. Aberle, Daniel Aletaha, Leonhard X. Heinz, Michael Bonelli

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: